Practice with mock tests, learn from structured notes, and get your questions answered by a global forensic community, all in one place.
Salivary amylase is the primary biochemical marker used to detect saliva on forensic exhibits, supported by the RSID-Saliva immunochromatographic assay. This topic covers Phadebas and RSID testing, sensitivity and specificity considerations, and best practices for collection and reporting.
Last updated:
Saliva turns up on bite marks, licked stamps, cigarette butts, food remnants, and the rim of a bottle. It looks like nothing, dries colourless, and can sit on a surface for months. Yet hidden inside that invisible film is one of the most abundant enzymes in the human body: alpha-amylase. Detect it at the right concentration, with the right assay, and you have a defensible marker that the fluid deposited on an exhibit was saliva.
The forensic biology of saliva has two main chapters. The first is colorimetric: the Phadebas starch-cleavage test, which has been used in crime laboratories since the 1970s and remains a rapid, cheap screening tool. The second is immunological: the RSID-Saliva lateral-flow strip, which uses antibodies raised against the salivary isoform of amylase and is far more specific. Neither test proves a DNA profile, but either can justify submitting a swab for short tandem repeat analysis and can help explain which body fluid deposited a mixed stain.
There is a complication worth knowing from the start. Salivary amylase is not the only amylase in the human body. The pancreas produces a structurally similar enzyme, and both can end up on exhibits in realistic crime-scene scenarios. Knowing what each assay actually detects, and where the cross-reactivity lives, is what separates a reportable positive from a misleading one.
An invisible fluid that outlasts its deposit by months.
Saliva is deposited during biting, oral contact, speaking at close range, spitting, and the handling of food or drink items. Each of these actions produces a biological trace that, once dried, is chemically stable. Salivary alpha-amylase has been detected in stains stored at room temperature for over a year, which means collection does not always have to be immediate, though delay adds uncertainty.
The forensic relevance goes beyond saliva identification itself. Saliva contains epithelial cells shed from the oral mucosa, and those cells carry nuclear DNA. Identifying a stain as saliva therefore sets up the next analytical step: STR profiling to establish who deposited it. The amylase test is not the endpoint; it is the gateway.
A tablet that turns blue when amylase has been at work.
Phadebas tablets were developed commercially as a clinical diagnostic for salivary amylase in the 1960s and were adopted by forensic laboratories as a screening tool shortly after. Each tablet contains an insoluble starch cross-linked to a blue dye. When alpha-amylase cleaves the starch backbone, the attached dye becomes soluble and releases into solution, producing a blue colour measurable by eye or by spectrophotometer at 620 nm.
Antibodies trained on the salivary isoform cut false positives substantially.
RSID-Saliva is manufactured by Independent Forensics (now part of Thermo Fisher Scientific) and uses lateral-flow immunochromatography, the same platform as a home pregnancy test. The test strip carries two antibody zones. The first is loaded with monoclonal antibodies specific to human salivary amylase; the second is a control line. When extract is applied to the sample well, salivary amylase in the extract binds the detector antibody, migrates along the strip, and produces a visible pink or red line at the test zone.
| Feature | Phadebas | RSID-Saliva |
|---|---|---|
| Principle | Colorimetric enzyme activity assay | Immunochromatographic lateral flow |
| Analyte detected | All alpha-amylase isoforms | Human salivary amylase (AMY1) |
| Specificity | Lower; pancreatic and plant amylase give positives | Higher; antibody-based discrimination |
| Sensitivity threshold | ~1:1000 dilution of saliva | ~1:500 to 1:1000 dilution |
| Time to result | 30-60 minutes with incubation | 5-10 minutes |
| Cost per test | Very low | Moderate |
Validation studies have found RSID-Saliva to be negative or only weakly reactive with semen, blood, vaginal fluid, and sweat at concentrations relevant to casework, which makes it genuinely useful as a confirmatory screen. That said, a small number of studies have reported that very high concentrations of pancreatic amylase can occasionally give a faint test band; context and the full case picture always matter.
Recovery technique directly controls the quantity of amylase available for testing.
The double-swab technique, described by Sweet and colleagues in 1997, remains the standard for bite-mark saliva recovery. A sterile cotton or foam swab is moistened with distilled water and rolled over the suspected deposition area in a circular pattern, then immediately followed by a dry swab to pick up the material loosened and rehydrated by the first pass. Both swabs are submitted.
A positive result needs context; a negative result needs even more.
Sensitivity studies have shown that Phadebas can detect amylase in saliva diluted to approximately 1:1000 or 1:2000, which means even a very small stain contains detectable enzyme. This is good for catching low-volume deposits, but the same sensitivity means that sources of amylase other than saliva are also picked up at low concentrations.
RSID-Saliva improves specificity by targeting the human salivary isoform, but no immunoassay is perfectly specific in all realistic casework conditions. Vaginal fluid can contain salivary amylase if oral contact occurred, which is not a contamination artifact but a genuine reflection of how secretions mix in sexual assault cases. Reporting needs to acknowledge that a positive RSID result on vaginal swabs does not automatically mean oral contact: cross-contamination at collection is another explanation.
A negative result from Phadebas and RSID-Saliva does not prove saliva is absent. Degradation by UV light, extreme temperature, cleaning products, or simple passage of time can reduce amylase below the detection threshold. As with all trace evidence, the absence-of-evidence principle applies: failure to detect is not proof of non-deposition.
The assay tells you about amylase; the report must say what that means about saliva.
A well-constructed saliva report distinguishes between levels of inference. The first level is analytical: amylase activity was detected at a concentration consistent with a salivary deposit. The second level is inferential: this is consistent with saliva being present on the exhibit. The third level is contextual: given the exhibit type and case circumstances, oral contact is one explanation.
Courts in the UK and elsewhere have accepted amylase evidence when properly qualified. The key is honesty about the specificity of the assay used. A Phadebas-only positive should be reported as indicating the presence of alpha-amylase, with the note that salivary origin is the most likely but not the exclusive explanation. An RSID-Saliva positive supports a narrower claim of human salivary amylase detected, which is a stronger foundation for arguing oral contact.
| Assay result | Appropriate report language | Limitations to note |
|---|---|---|
| Phadebas positive only | Alpha-amylase detected; consistent with salivary deposit | Cannot exclude pancreatic or plant amylase |
| RSID-Saliva positive | Human salivary amylase detected; consistent with saliva | Very high pancreatic amylase possible weak reaction |
| Both negative | No amylase detected; saliva not confirmed | Degradation or dilution may have reduced below threshold |
| Discordant (Phadebas+, RSID-) | Alpha-amylase detected but salivary origin not confirmed | Consider non-salivary amylase source |
Why is the Phadebas test considered a presumptive rather than a confirmatory test for saliva?
Test yourself on Forensic Serology with free, timed mocks.
Practice Forensic Serology questionsSpotted an error in this page? Report a correction or read our editorial standards.